Corporate Information
CEO Message
Mission
Corporate Information
Corporate Governance
Business
Stemrim History
About “Regeneration-Inducing Medicine
™
”
What is “Regeneration-Inducing Medicine
™
”?
Issues of Conventional Cell Therapy
The Superiority of “Regeneration-Inducing Medicine
™
”
Business
Areas of Disease and Pipeline
“Regeneration-Inducing Medicine
™
”
Autologous cell sampling devices for medical treatment
Stem cells gene therapy
Research Paper
Investor Relations
COO Message
Investor News
ESG
Financial Data
Investor Library
Investor Calendar
Analyst Coverage
Stock Prices
Investor Relations
Financial Results(past list)
2024
December 12, 2024
[Delayed]Non-consolidated Financial Results for Three Months Ended October 31, 2024 [Japanese GAAP]
September 11, 2024
Non-consolidated Financial Results for the Fiscal Year Ended July 31, 2024 [Japanese GAAP]
June 12, 2024
Non-consolidated Financial Results for the Nine Months Ended April 30, 2024 [Japanese GAAP]
March 13, 2024
Non-consolidated Financial Results for the Six Months Ended January 31, 2024[Japanese GAAP]
2023
December 13, 2023
Non-consolidated Financial Results for the Three Months Ended October 31, 2023[Japanese GAAP]
September 13, 2023
Non-consolidated Financial Results for the Fiscal Year Ended July 31, 2023[Japanese GAAP]
June 19, 2023
[Delayed]Non-consolidated Financial Results for the Nine Months Ended April 30, 2023[Japanese GAAP]
March 16, 2023
[Delayed]Non-consolidated Financial Results for the Six Months Ended January 31, 2023[JapaneseGAAP]
2022
December 14, 2022
[Delayed]Non-consolidated Financial Results for the Three Months Ended October 31, 2022[JapaneseGAAP]
September 08, 2022
[Delayed]Non-consolidated Financial Results for the Fiscal Year Ended July 31, 2022[Japanese GAAP]
June 09, 2022
[Delayed]Non-consolidated Financial Results for the Nine Months Ended April 30, 2022[Japanese GAAP]
March 16, 2022
[Delayed]Non-consolidated Financial Results for the Six Months Ended January 31, 2022[JapaneseGAAP]
2021
December 12, 2021
[Delayed]Non-consolidated Financial Results for the Three Months Ended October 31, 2021[JapaneseGAAP]
September 09, 2021
[Delayed]Non-consolidated Financial Results for the Fiscal Year Ended July 31, 2021[Japanese GAAP]
June 10, 2021
[Delayed]Non-consolidated Financial Results for the Nine Months Ended April 30, 2021[Japanese GAAP]
March 11, 2021
[Delayed]Non-consolidated Financial Results for the Six Months Ended January 31, 2021[Japanese GAAP]
2020
December 12, 2020
[Delayed]Non-consolidated Financial Results for the Three Months Ended October 31, 2020[Japanese GAAP]
September 10, 2020
[Delayed]Non-consolidated Financial Results for the Fiscal Year Ended July 31, 2020[Japanese GAAP]
June 11, 2020
[Delayed]Non-consolidated Financial Results for the Nine Months Ended April 30, 2020[Japanese GAAP]
March 11, 2020
[Delayed]Non-consolidated Financial Results for the Six Months Ended January 31, 2020[Japanese GAAP]
2019
December 12, 2019
[Delayed]Non-consolidated Financial Results for the Three Months Ended October 31, 2019[Japanese GAAP]
September 12, 2019
[Delayed]Non-consolidated Financial Results for the Fiscal Year Ended July 31, 2019 [Japanese GAAP]
StemRIM
>
Investor Relations
>
Investor Library
>
Financial Results
>
Financial Results(past list)